z-logo
Premium
TENSION‐TYPE HEADACHE
Publication year - 2004
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.2004.04086_7.x
Subject(s) - tenderness , medicine , placebo , anesthesia , stimulus (psychology) , peripheral , surgery , pathology , psychology , alternative medicine , psychotherapist
Tenderness is the most prominent abnormal finding in patients with tension‐type headache (TTH). Recently we developed a model of myofascial tenderness using intramuscular infusion of a combination of bradykinin, serotonin, histamine and prostaglandin E2. We aimed to examine tenderness after this combination in patients with episodic TTH (ETTH). Fifteen patients and 15 healthy controls completed the study. Participants received the combination into the non‐dominant trapezius muscle in a randomized, double‐blinded and placebo‐controlled design. Local tenderness and stimulus‐response functions, mechanical pain thresholds (PPDT) in the temporal region and on the finger, and total tenderness score (TTS) were recorded. A local, prolonged, and mild to moderate tenderness was reported both in patients ( P = 0.001) and in controls ( P = 0.001) after the combination compared with the placebo. The response to the combination tended to be increased in patients. The stimulus‐response function was leftward shifted after the combination, compared with baseline in both groups. No changes in PPDT or TTS were found after the infusions, whereas baseline PPDTs were decreased in ETTH compared with controls (PPDT finger: P = 0.033; PPDT temporal: P = 0.015). Intramuscular infusion of a combination of endogenous substances induced prolonged tenderness in both patients with episodic TTH and healthy subjects. The present results suggest an increased excitability of peripheral muscle afferents in TTH.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here